Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Other Accumulated Expenses (2023 - 2025)

Camp4 Therapeutics' Other Accumulated Expenses history spans 3 years, with the latest figure at $27000.0 for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 84.66% to $27000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $27000.0, a 84.66% decrease, with the full-year FY2025 number at $27000.0, down 84.66% from a year prior.
  • Other Accumulated Expenses hit $27000.0 in Q4 2025 for Camp4 Therapeutics, down from $176000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for CAMP hit a ceiling of $369000.0 in Q3 2024 and a floor of $27000.0 in Q4 2025.
  • Historically, Other Accumulated Expenses has averaged $215250.0 across 3 years, with a median of $232500.0 in 2023.
  • Biggest five-year swings in Other Accumulated Expenses: crashed 39.1% in 2024 and later tumbled 84.66% in 2025.
  • Tracing CAMP's Other Accumulated Expenses over 3 years: stood at $289000.0 in 2023, then crashed by 39.1% to $176000.0 in 2024, then tumbled by 84.66% to $27000.0 in 2025.
  • Business Quant data shows Other Accumulated Expenses for CAMP at $27000.0 in Q4 2025, $176000.0 in Q4 2024, and $369000.0 in Q3 2024.